Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
CCAP Stock Summary
Top 10 Correlated ETFs
CCAP
In the News
Is It Worth Investing in Crescent Capital BDC (CCAP) Based on Wall Street's Bullish Views?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Crescent Capital BDC (CCAP) Increases Yet Falls Behind Market: What Investors Need to Know
Crescent Capital BDC (CCAP) closed at $17.50 in the latest trading session, marking a +0.81% move from the prior day.
3 SBIC & Commercial Finance Stocks to Buy Amid Grim Industry Prospects
Weak asset quality, high rates and macroeconomic woes are likely to hurt Zacks SBIC & Commercial Finance industry players like Bain Capital (BCSF), Barings BDC (BBDC) and Crescent Capital (CCAP). Yet, decent financing demand across sectors is likely to aid.
Here's Why Crescent Capital BDC (CCAP) Fell More Than Broader Market
Crescent Capital BDC (CCAP) closed at $16.99 in the latest trading session, marking a -1.51% move from the prior day.
Crescent Capital Is Well Set To Sustain Gains Over The Long Term
Crescent Capital is a top BDC with the potential for solid long-term returns and downside protection through diversified debt investments. The company's outlook for 2024 is promising due to growth trends in the leveraged buyout market and improving end markets. CCAP is well-positioned to benefit from increased LBO activity with strong relationships with private equity sponsors and solid liquidity.
Is Crescent Capital BDC (CCAP) a Buy as Wall Street Analysts Look Optimistic?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Crescent Capital BDC (CCAP) Increases Despite Market Slip: Here's What You Need to Know
In the closing of the recent trading day, Crescent Capital BDC (CCAP) stood at $16.27, denoting a +0.93% change from the preceding trading day.
Crescent Capital BDC (CCAP) Stock Dips While Market Gains: Key Facts
The latest trading day saw Crescent Capital BDC (CCAP) settling at $16.12, representing a -0.31% change from its previous close.
Crescent Capital BDC, Inc. Schedules Earnings Release and Conference Call to Discuss its Fourth Quarter and Fiscal Year Ended December 31, 2023 Financial Results
LOS ANGELES, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Crescent Capital BDC, Inc. (“Crescent BDC”) (NASDAQ: CCAP) today announced it will release its financial results for the fourth quarter and fiscal year ended December 31, 2023 on Wednesday, February 21, 2024 after market close. Crescent BDC invites all interested persons to attend its webcast/conference call on Thursday, February 22, 2024 at 12:00 p.m. Eastern Time to discuss its fourth quarter and fiscal year ended December 31, 2023 financial results.
Crescent Capital BDC (CCAP) Stock Sinks As Market Gains: Here's Why
In the closing of the recent trading day, Crescent Capital BDC (CCAP) stood at $16.54, denoting a -0.72% change from the preceding trading day.
CCAP Financial details
CCAP Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.84 | 1.68 | 2.86 | 0.73 | 2.57 | |
Net income per share | 0.97 | 1.98 | 2.94 | 0.56 | 2.33 | |
Operating cash flow per share | -6.76 | -2.23 | -5.54 | 1.01 | 2.57 | |
Free cash flow per share | -6.76 | -2.23 | -5.54 | 1.01 | 2.57 | |
Cash per share | 0.15 | 0.07 | 0.35 | 0.23 | 0.68 | |
Book value per share | 13.55 | 20.23 | 22.91 | 22.13 | 20.67 | |
Tangible book value per share | 13.55 | 20.23 | 22.91 | 22.13 | 20.67 | |
Share holders equity per share | 13.55 | 20.23 | 22.91 | 22.13 | 20.67 | |
Interest debt per share | 11.12 | 17.61 | 22.85 | 24.79 | 25.04 | |
Market cap | 492.64M | 403.32M | 501.21M | 353.77M | 624.43M | |
Enterprise value | 810.08M | 873.36M | 1.12B | 1B | 1.46B | |
P/E ratio | 16.83 | 7.38 | 5.99 | 22.76 | 7.45 | |
Price to sales ratio | 19.49 | 8.67 | 6.16 | 17.49 | 6.75 | |
POCF ratio | -2.43 | -6.53 | -3.18 | 12.66 | 6.77 | |
PFCF ratio | -2.43 | -6.53 | -3.18 | 12.66 | 6.77 | |
P/B Ratio | 1.21 | 0.72 | 0.77 | 0.58 | 0.84 | |
PTB ratio | 1.21 | 0.72 | 0.77 | 0.58 | 0.84 | |
EV to sales | 32.05 | 18.77 | 13.8 | 49.54 | 15.81 | |
Enterprise value over EBITDA | 27.33 | 15.76 | 12.86 | 22.05 | 17.38 | |
EV to operating cash flow | -3.99 | -14.13 | -7.12 | 35.84 | 15.83 | |
EV to free cash flow | -3.99 | -14.13 | -7.12 | 35.84 | 15.83 | |
Earnings yield | 0.06 | 0.14 | 0.17 | 0.04 | 0.13 | |
Free cash flow yield | -0.41 | -0.15 | -0.31 | 0.08 | 0.15 | |
Debt to equity | 0.79 | 0.84 | 0.97 | 1.07 | 1.14 | |
Debt to assets | 0.43 | 0.45 | 0.48 | 0.5 | 0.52 | |
Net debt to EBITDA | 10.71 | 8.48 | 7.11 | 14.26 | 9.95 | |
Current ratio | 0.63 | 0.37 | 1.74 | 0.76 | 1.47 | |
Interest coverage | 2.46 | 3.58 | 4.42 | 1.52 | 1.53 | |
Income quality | -6.93 | -1.13 | -1.89 | 1.8 | 1.1 | |
Dividend Yield | 0.05 | 0.11 | 0.1 | 0.16 | 0.1 | |
Payout ratio | 0.84 | 0.78 | 0.57 | 3.56 | 0.77 | |
Sales general and administrative to revenue | 0.14 | 0.1 | 0.06 | 0.22 | 0.05 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 293.76K | 0.66 | 164.37 | 0 | 0.44 | |
Graham number | 17.24 | 29.98 | 38.9 | 16.72 | 32.94 | |
ROIC | 0.04 | 0.05 | 0.07 | 0.04 | 0.05 | |
Return on tangible assets | 0.04 | 0.05 | 0.06 | 0.01 | 0.05 | |
Graham Net | -11.1 | -17.34 | -22.45 | -23.95 | -23.65 | |
Working capital | -4.53M | -9.71M | 13.53M | -5.3M | 12.38M | |
Tangible asset value | 406.92M | 560M | 652.29M | 612.54M | 742.59M | |
Net current asset value | -332.69M | -488.39M | -633.82M | -673.99M | -846.32M | |
Invested capital | 0.79 | 0.84 | 0.97 | 1.07 | 1.14 | |
Average receivables | 2.18M | 3.43M | 12.75M | 15.79M | 12.1M | |
Average payables | 9.8M | 13.79M | 16.82M | 19.91M | 23.87M | |
Average inventory | 0.5 | 9.36M | 9.36M | 13.51M | 13.51M | |
Days sales outstanding | 43.21 | 30.32 | 97.09 | 179.58 | 56.26 | |
Days payables outstanding | 940.52 | 834.66 | 340.73 | 386.08 | 260.25 | |
Days of inventory on hand | 0 | 1.01K | 0 | 481.81 | 0 | |
Receivables turnover | 8.45 | 12.04 | 3.76 | 2.03 | 6.49 | |
Payables turnover | 0.39 | 0.44 | 1.07 | 0.95 | 1.4 | |
Inventory turnover | 4.7M | 0.36 | 19.47M | 0.76 | 0 | |
ROE | 0.07 | 0.1 | 0.13 | 0.03 | 0.11 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.17 | 0.31 | 0.66 | 1.3 | 0.89 | |
Net income per share | 0.09 | 0.24 | 0.61 | 0.61 | 0.83 | |
Operating cash flow per share | 1.51 | 0.49 | 0.55 | 0.58 | 0.93 | |
Free cash flow per share | 1.51 | 0.49 | 0.55 | 0.58 | 0.93 | |
Cash per share | 0.23 | 0.66 | 0.58 | 0.61 | 0.21 | |
Book value per share | 22.13 | 22.13 | 19.58 | 19.7 | 20.04 | |
Tangible book value per share | 22.13 | 22.13 | 19.58 | 19.7 | 20.04 | |
Share holders equity per share | 22.13 | 22.13 | 19.58 | 19.7 | 20.04 | |
Interest debt per share | 24.01 | 27.33 | 23.57 | 23.5 | 23.19 | |
Market cap | 353.77M | 442.18M | 561.11M | 633.75M | 644.13M | |
Enterprise value | 1B | 1.3B | 1.41B | 1.48B | 1.48B | |
P/E ratio | 33.99 | 14.21 | 6.21 | 7 | 5.22 | |
Price to sales ratio | 73.98 | 44.38 | 22.89 | 13.16 | 19.5 | |
POCF ratio | 8.45 | 27.62 | 27.59 | 29.68 | 18.62 | |
PFCF ratio | 8.45 | 27.62 | 27.59 | 29.68 | 18.62 | |
P/B Ratio | 0.58 | 0.62 | 0.77 | 0.87 | 0.87 | |
PTB ratio | 0.58 | 0.62 | 0.77 | 0.87 | 0.87 | |
EV to sales | 209.5 | 130.12 | 57.63 | 30.83 | 44.84 | |
Enterprise value over EBITDA | 76.53 | 67.89 | 63.28 | 67.25 | 47.82 | |
EV to operating cash flow | 23.94 | 81 | 69.47 | 69.52 | 42.8 | |
EV to free cash flow | 23.94 | 81 | 69.47 | 69.52 | 42.8 | |
Earnings yield | 0.01 | 0.02 | 0.04 | 0.04 | 0.05 | |
Free cash flow yield | 0.12 | 0.04 | 0.04 | 0.03 | 0.05 | |
Debt to equity | 1.07 | 1.22 | 1.18 | 1.17 | 1.14 | |
Debt to assets | 0.5 | 0.54 | 0.53 | 0.53 | 0.52 | |
Net debt to EBITDA | 49.5 | 44.74 | 38.15 | 38.54 | 27.02 | |
Current ratio | 0.76 | 1.57 | 1.35 | 1.63 | 0.84 | |
Interest coverage | 1.28 | 1.69 | 1.56 | 1.53 | 2.09 | |
Income quality | 16.08 | 2.06 | 0.9 | 0.94 | 1.12 | |
Dividend Yield | 0.04 | 0.03 | 0.03 | 0.03 | 0.03 | |
Payout ratio | 4.87 | 1.63 | 0.67 | 0.8 | 0.6 | |
Sales general and administrative to revenue | 0.23 | 0.12 | 0.05 | 0.02 | 0.04 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | -0.03 | 0.03 | 0 | |
Graham number | 6.84 | 10.92 | 16.38 | 16.45 | 19.37 | |
ROIC | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | |
Return on tangible assets | 0 | 0 | 0.01 | 0.01 | 0.02 | |
Graham Net | -23.95 | -26.96 | -23.43 | -22.99 | -22.85 | |
Working capital | -5.3M | 12.73M | 8.64M | 14.36M | -4.06M | |
Tangible asset value | 612.54M | 718.42M | 725.81M | 730.27M | 742.59M | |
Net current asset value | -673.99M | -877.82M | -865.59M | -857.04M | -862.75M | |
Invested capital | 1.07 | 1.22 | 1.18 | 1.17 | 1.14 | |
Average receivables | 9.17M | 15.55M | 16.45M | 18.88M | 20.12M | |
Average payables | 19.73M | 21.91M | 23.38M | 23.71M | 24.46M | |
Average inventory | 13.51M | 13.51M | 0.5 | 0 | 19.36M | |
Days sales outstanding | 187.26 | 190.97 | 43.2 | 48.59 | 38.83 | |
Days payables outstanding | 319.73 | 249.02 | 239.55 | 215.18 | 239.72 | |
Days of inventory on hand | 399 | 0 | 0 | 0 | 355.71 | |
Receivables turnover | 0.48 | 0.47 | 2.08 | 1.85 | 2.32 | |
Payables turnover | 0.28 | 0.36 | 0.38 | 0.42 | 0.38 | |
Inventory turnover | 0.23 | 8.01M | 0 | 0 | 0.25 | |
ROE | 0 | 0.01 | 0.03 | 0.03 | 0.04 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
CCAP Frequently Asked Questions
What is Crescent Capital BDC, Inc. stock symbol ?
Crescent Capital BDC, Inc. is a US stock , located in Los angeles of Ca and trading under the symbol CCAP
Is Crescent Capital BDC, Inc. buy or a sell ?
1 stock analysts have 1 predictions with a medium analyst target price of $18.5. The lowest prediction is $18.5 and the highest is $18.5
What is CCAP stock prediction ?
What is Crescent Capital BDC, Inc. stock quote today ?
Crescent Capital BDC, Inc. stock price is $17.345 today.
Is Crescent Capital BDC, Inc. stock public?
Yes, Crescent Capital BDC, Inc. is a publicly traded company.